NCT02864316View on ClinicalTrials.gov

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

September 30, 2018

Conditions

Solid Tumors Induced by Prior Radiation Exposure

Interventions

DRUG

Nivolumab

Trial Locations (1)

21231

Sidney Kimmel Cancer Center @ Johns Hopkins, Baltimore

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER